首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1439407

全球快速診斷試劑盒市場：洞察、競爭格局、市場預測：2030 年

Rapid Diagnostic Kits - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 按訂單生產 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

2023年全球快速診斷試劑盒市場規模為141.2億美元。預計到 2030 年，該市場將達到 173.8 億美元，2024 年至 2030 年的預測期內複合年增長率為 3.55%。快速診斷試劑盒市場的強勁成長是由全球糖尿病盛行率上升、COVID-19盛行率上升、人類免疫缺陷病毒（HIV）感染率上升以及市場對快速診斷試劑盒的監管批准增加所推動的。床邊免疫診斷測試是2024-2030 年預測期內推動快速診斷試劑盒市場的主要因素。

由於全球糖尿病盛行率上升等多種因素，快速診斷試劑盒市場目前正在經歷良好的成長。根據國際糖尿病聯盟2022年的數據，約有5.37億成年人（20-79歲）患有糖尿病。根據上述消息來源，2030年全球將有6.43億人患有糖尿病，2045年將有7.83億人患有糖尿病。

此外，推動快速診斷試劑盒市場成長的另一個重要因素是COVID-19盛行率的上升。例如，根據世界衛生組織 2022 年 6 月的公告，全球有 540,923,532 例確診的 COVID-19 病例，其中 6,325,785 例死亡。上述消息人士稱，2019年COVID-19激增推動了快速診斷試劑盒的需求和生產。透過採集人類的呼吸道樣本，可以透過快速診斷測試 (RDT) 檢測與 COVID-19 病毒相關的病毒蛋白質（抗原），從而確保快速、準確的診斷。因此，透過借助快速診斷試劑盒對病毒進行早期診斷，可以限制COVID-19疫情及其相關死亡的增加，這增加了對快速診斷試劑盒的需求，並推動了診斷試劑盒整體市場成長的飆升。套件。

該報告研究了全球快速診斷試劑盒市場，並提供了市場概述，包括按技術、應用、最終用戶、地區和參與市場的公司概況劃分的趨勢。

Advin Health Care
ACON Laboratories Inc
Abbott
Artron Laboratories Inc
Alfa Scientific Designs Inc
BD
BTNX Inc
bioMerieux SA
Cardinal Health
Lab-Care Diagnostics (India) Pvt. Ltd
Creative Diagnostics
Meridian Bioscience Inc
F. Hoffmann-La Roche Ltd
Trinity Biotech
WERFEN
Elabscience Biotechnology Inc
Innova Medical Group Inc
CTK Biotech Inc
Atlas Medical GmbH
Wondfo

第10章 KOL觀點

第十一章專案方法

第 12 章. 關於 DelveInsight

第十三章免責聲明與聯絡我們

簡介目錄圖表

Product Code: DIMDCL0205

Rapid Diagnostic Kits Market By Technology (Lateral Flow Tests, Immunoassay, Agglutination, And Solid Phase), By Application (Infectious Diseases, Fertility Tests, Glucose Monitoring, Cholestrol Monitoring And Others), By End User (Hospitals, Clinics, Home Care, And Diagnostic Centers), and by geography, is expected to grow at a significant CAGR forecast till 2030 owing to the rising prevalence of diabetes globally and the increasing prevalence of covid-19

The global rapid diagnostic kits market was valued at USD 14.12 billion in 2023, growing at a CAGR of 3.55% during the forecast period from 2024 to 2030, to reach USD 17.38 billion by 2030. The stellar growth observed in the rapid diagnostic kits market is primarily owing to the rising prevalence of diabetes globally, the increasing prevalence of COVID-19, the increasing incidence of Human Immunodeficiency Virus (HIV) infection, the increased regulatory approval of rapid diagnostics kits in the market, and the increase in demand of point-of-care immunodiagnostic tests are some of the factors propelling the market for rapid diagnostic kits during the forecast period from 2024 to 2030.

Rapid Diagnostic Kits Market Dynamics:

The rapid diagnostic kits market is witnessing lucrative growth at present owing to various factors such as the rising prevalence of diabetes globally. As per the International Diabetes Federation in 2022, around 537 million adults (20-79 years) were living with diabetes. According to the above mentioned source, by the year 2030, there will be 643 million people who will suffer from diabetics worldwide, and by the year 2045, there will be 783 million people suffering from the disease. Thus, the rapid diagnostics kits which includes the glucometer with strips which are used for the glucose monitoring for quick results. Therefore, this can boost the demand of rapid diagnostics kits, thereby, blostering the growth of rapid diagnostics kits overall market over the forecast period (2024-2030).

Moreover, another key factor that is responsible for the growth of the rapid diagnostics kits market is the increasing prevalence of COVID-19. For instance, according to the WHO June 2022, there have been 540,923,532 confirmed cases of COVID-19 all over the world including 6,325,785 deaths. As per the aforesaid source, the spike in COVID-19 cases in 2019 boosted the demand and production of rapid diagnostics kits. The viral proteins (antigens) associated with the COVID-19 virus can be detected by a rapid diagnostic test (RDT) by taking the sample of a person's respiratory tract, this assures a quick and accurate diagnosis. Therefore, the increasing prevalence of COVID-19 and deaths related to it can be limited by doing an early diagnosis of the virus with the help of rapid diagnostics kits, this increases the demand for rapid diagnostics kits which surges the rapid diagnostics kit's overall market growth.

Hence, all the aforementioned factors are anticipated to boost the global rapid diagnostic kits market during the forecast period.

However, the low sensitivity & accuracy of rapid diagnostic kits and stringent regulatory approval policies are some of the factors likely to impede the rapid diagnostic kits market growth.

Additionally, the ongoing COVID-19 pandemic has positively impacted the rapid diagnostics kits market. The surge in COVID-19 cases across the globe generated a huge demand for rapid diagnostics kits to detect the presence of disease in an individual. Home self-testing kits demand for COVID-19 increased as well as the severe shortage of rapid diagnostics kits related to glucose monitoring and others was reported. As the masses are vaccinated, relaxation in lockdown restrictions, resumption of supply chains, logistics, and manufacturing units, the rapid diagnostics kits overall market can be expected to further grow during the forecast period (2024-2030).

Rapid Diagnostic Kits Market Segment Analysis:

Rapid Diagnostic Kits Market by Technology (Lateral Flow Tests, Immunoassay, Agglutination, and Solid Phase), Application (Infectious Diseases, Fertility Tests, Glucose Monitoring, Cholestrol Monitoring, and Others), End-User (Hospitals, Clinics, Home Care, and Diagnostic Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the application segment of the rapid diagnostic kits market, the infectious diseases sub-segment is expected to hold the largest market share in the year 2023. This is because of the sudden spike of infectious diseases such as COVID-19 cases in 2019, rapid diagnostics kits helped in the early diagnosis of the virus. It acts as a useful technique for determining the clinical diagnosis of COVID-19 in which antibodies are spotted on nitrocellulose membranes and interact with certain antigens in the patient's sample. Some advantages of rapid diagnostics kits are people have easier access to the test, it allows the implementation of proper infection control measures early, which is critical in a pandemic, and it is an easy-to-use test that yields findings in 20 minutes or less, with little or no additional equipment needed. Thus, the benefits associated with the rapid diagnostics kits, its market demand increases which boosts its overall market growth.

Therefore, the surge in infectious diseases cases worldwide, can increase the demand for rapid diagnostics kits which could drive the growth of the overall rapid diagnostics kits market during the forecast period. However, various technological advanced products are launched in the market which are also expected to drive the market growth. For instance, in January 2022, Roche Diagnostics, the world's largest biotech company, announced the release of the COVID-19 At-Home Test, their newest diagnostic solution. The ICMR has authorized the over-the-counter test for the identification of SARS CoV-2 infection in those who have symptoms that are similar to COVID-19.

Further, in July 2022, Abbott, a global healthcare leader announced the launch of the Panbio(TM) COVID-19 Antigen Self-Test for the detection of the SARS-CoV-2 virus in adults and children with or without symptoms.

Hence, all the above-mentioned factors are anticipated to contribute to the growth of the rapid diagnostic kits market during the forecast period.

North America is expected to dominate the overall Rapid Diagnostic Kits Market:

Among all the regions, North America is expected to occupy a major share in the global rapid diagnostic kits market in the year 2023 and continue to do the same during the forecast period from 2024 to 2030. Factors such as the increasing incidence of HIV infections and the increasing regulatory approval of rapid diagnostics kits in the market are expected to increase the demand for rapid diagnostics kits in the North America market.

According to HIV.gov in 2019, in United States, 34,800 new cases of HIV infections were estimated with the rate of 12.6 per 100,000 people. Therefore, rapid diagnostics kits can be used for the diagnosis of the HIV infection, this can uplift the demand of rapid diagnostics kits, which could boost the rapid diagnostics kits overall market.

Furthermore, pregnancy test kits are utilized to detect the pregnancy in the women. Thus, due to surge in pregnancy and birth rates, regulatory approval of pregnancy diagnostics kits has increased in the market, which can also drive the rapid diagnostics kits overall market. For instance, in December 2020, ACON Laboratories Inc., a leading global of rapid tests, point of care diagnostics and medical devices announced that it has received FDA Over The Counter (OTC) clearance for its Distinct® Early Detection Pregnancy test in the United States.

Therefore, due to interplay of the factors mentioned above, there will be high demand of rapid diagnostics kits, which would provide a conducive growth environment for the North American region in the rapid diagnostics kits market.

Rapid Diagnostic Kits Market Key Players:

Some of the key market players operating in the rapid diagnostic kits market include Advin Health Care, ACON Laboratories Inc, Abbott, Artron Laboratories Inc, Alfa Scientific Designs Inc, BD, BTNX Inc, bioMerieux SA, Cardinal Health, Lab-Care Diagnostics (India) Pvt. Ltd., Creative Diagnostics, Meridian Bioscience Inc, F. Hoffmann-La Roche Ltd, Trinity Biotech, WERFEN, Elabscience Biotechnology Inc, Innova Medical Group Inc, CTK Biotech Inc , Atlas Medical GmbH, Wondfo, and others.

Recent Developmental Activities in the Rapid Diagnostic Kits Market:

In February 2022, Kenya's Ministry of Health launched malaria and COVID-19 PCR diagnostic kits in a bid to increase the timely detection and treatment of both infections.

In June 2022, MyLab Discovery Solutions announced the commercial launch of their COVID-19 self-test kit CoviSelf in India after getting approval from the Indian Council for Medical Research (ICMR). It can detect the virus within 15 minutes. It is the first test kit for Covid-19 that can be self-administered by citizens at home.

In March 2020, Biolidics Limited, a medical technology firm, announced the debut of their quick test kit for the Novel Coronavirus 2019 ("COVID-19") in Singapore, as well as a manufacturing agreement with a diagnostic kit manufacturer to customize and produce the rapid test kits.

Key Takeaways from the Rapid Diagnostic Kits Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the rapid diagnostic kits market.
Top key product/services/technology developments, mergers, acquisitions, partnerships, joint ventures happened over the last 3 years
Key companies dominating the Global rapid diagnostic kits Market
Various opportunities available for the other competitor in the rapid diagnostic kits Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030.
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for rapid diagnostic kits market growth in the coming future?

Target Audience who can be benefited from the Rapid Diagnostic Kits Market Report Study

Rapid diagnostic kits providers
Research organizations and consulting companies
Rapid diagnostic kits-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in Rapid Diagnostic Kits
Various End-users who want to know more about the Rapid Diagnostic Kits Market and the latest technological developments in the Rapid Diagnostic Kits market.

Frequently Asked Questions for the Rapid Diagnostic Kits Market:

1. What is Rapid Diagnostic Kits?

Rapid Diagnostic Kits help in point-of-care diagnosis, which means they're designed to give patients diagnostic findings quickly and easily while they're still at the hospital, screening site, or other health care provider.

2. What is the market for Global Rapid Diagnostic Kits?

The global Rapid Diagnostic Kits Market was valued at USD 14.12 billion in 2023, growing at a CAGR of 3.55% during the forecast period from 2024 to 2030 to reach USD 17.38 billion by 2030.

3. What are the drivers for Global Rapid Diagnostic Kits?

The major factor driving the demand for rapid diagnostic kits are the rising prevalence of diabetes globally, the increasing prevalence of COVID-19, the increasing incidence of Human Immunodeficiency Virus (HIV) infection, the increased regulatory approval of rapid diagnostics kits in the market, and increase in the demand of point-of-care immunodiagnostic tests

4. What are the key players operating in Global Rapid Diagnostic Kits?

5. Which region has the highest share in the Rapid Diagnostic Kits market?

Among all the regions, North America is expected to occupy a major share in the global rapid diagnostic kits market in the year 2023. This domination is owing to the increasing incidence of Human Immunodeficiency Virus (HIV) infection and the increased regulatory approval of rapid diagnostics kits in the market contributes to the growth of the rapid diagnostics kits market in the North America region.

1.Rapid Diagnostic Kits Market Report Introduction

2.Rapid Diagnostic Kits Market Executive summary

2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment

3. Regulatory Analysis

3.1. The United States
3.2. Europe
3.3. Japan
3.4. China

4. Rapid Diagnostic Kits Market Key factors analysis

4.1. Rapid Diagnostic Kits Market Drivers
- 4.1.1. The Rising Prevalence of Diabetes Globally
- 4.1.2. The Increasing Incidence of Human Immunodeficiency Virus (HIV) Infection
- 4.1.3. The Increasing Prevalence of COVID-19 Cases
- 4.1.4. The Increasing Regulatory Approval of Rapid Diagnostics Kits in the Market
4.2. Rapid Diagnostic Kits Market Restraints and Challenges
- 4.2.1. Low Sensitivity & accuracy of rapid diagnostics kits products
- 4.2.2. Stringent regulatory approval for rapid diagnostics kits
4.3. Rapid Diagnostic Kits Market Opportunities
- 4.3.1. Rising Market Launch of Rapid Diagnostics Kits Globally
- 4.3.2. A surge in Home Use Applications of the Rapid Diagnostics Kits

5. Rapid Diagnostic Kits Porter's Five Forces Analysis

5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Rapid Diagnostic Kits Market

7. Rapid Diagnostic Kits Market layout

7.1. By Technology
- 7.1.1. Lateral Flow Tests
- 7.1.2. Immunoassay
- 7.1.3. Agglutination
- 7.1.4. Solid Phase
7.2. By Application
- 7.2.1. Infectious Diseases
- 7.2.2. Fertility Tests
- 7.2.3. Glucose Monitoring
- 7.2.4. Cholesterol Monitoring
- 7.2.5. Others
7.3. By End-User
- 7.3.1. Hospitals
- 7.3.2. Clinics
- 7.3.3. Home Care
- 7.3.4. Diagnostics Centers
7.4. By Geography
- 7.4.1. North America
  - 7.4.1.1. United States Rapid Diagnostics Kits Market Size in USD million (2019- 2030)
  - 7.4.1.2. Canada Rapid Diagnostics Kits Market Size in USD million (2021-2030)
  - 7.4.1.3. Mexico Rapid Diagnostics Kits Market Size in USD million (2021-2030)
- 7.4.2. Europe
  - 7.4.2.1. France Rapid Diagnostics Kits Market Size in USD million (2021-2030)
  - 7.4.2.2. Germany Rapid Diagnostics Kits Market Size in USD million (2021-2030)
  - 7.4.2.3. United Kingdom Rapid Diagnostics Kits Market Size in USD million (2021-2030)
  - 7.4.2.4. Italy Rapid Diagnostics Kits Market Size in USD million (2021-2030)
  - 7.4.2.5. Spain Rapid Diagnostics Kits Market Size in USD million (2021-2030)
  - 7.4.2.6. Russia Rapid Diagnostics Kits Market Size in USD million (2021-2030)
  - 7.4.2.7. Rest of Europe Rapid Diagnostics Kits Market Size in USD million (2021-2030)
- 7.4.3. Asia-Pacific
  - 7.4.3.1. China Rapid Diagnostics Kits Market Size in USD million (2021-2030)
  - 7.4.3.2. Japan Rapid Diagnostics Kits Market Size in USD million (2021-2030)
  - 7.4.3.3. India Rapid Diagnostics Kits Market Size in USD million (2021-2030)
  - 7.4.3.4. Australia Rapid Diagnostics Kits Market Size in USD million (2021-2030)
  - 7.4.3.5. South Korea Rapid Diagnostics Kits Market Size in USD million (2021-2030)
  - 7.4.3.6. Rest of Asia Pacific Rapid Diagnostics Kits Market Size in USD million (2021-2030)
- 7.4.4. Rest of the World (RoW)
  - 7.4.4.1. Middle East Rapid Diagnostics Kits Market Size in USD million (2021-2030)
  - 7.4.4.2. Africa Rapid Diagnostics Kits Market Size in USD million (2021-2030)
  - 7.4.4.3. South America Rapid Diagnostics Kits Market Size in USD million (2021-2030)

8. Rapid Diagnostic Kits Global Company Share Analysis - Key 3-5 Companies

9. Rapid Diagnostic Kits Company and Product Profiles

9.1. Advin Health Care
- 9.1.1. Company Overview
- 9.1.2. Company Snapshot
- 9.1.3. Financial Overview
- 9.1.4. Product Listing
- 9.1.5. Entropy
9.2. ACON Laboratories Inc
- 9.2.1. Company Overview
- 9.2.2. Company Snapshot
- 9.2.3. Financial Overview
- 9.2.4. Product Listing
- 9.2.5. Entropy
9.3. Abbott
- 9.3.1. Company Overview
- 9.3.2. Company Snapshot
- 9.3.3. Financial Overview
- 9.3.4. Product Listing
- 9.3.5. Entropy
9.4. Artron Laboratories Inc
- 9.4.1. Company Overview
- 9.4.2. Company Snapshot
- 9.4.3. Financial Overview
- 9.4.4. Product Listing
- 9.4.5. Entropy
9.5. Alfa Scientific Designs Inc
- 9.5.1. Company Overview
- 9.5.2. Company Snapshot
- 9.5.3. Financial Overview
- 9.5.4. Product Listing
- 9.5.5. Entropy
9.6. BD
- 9.6.1. Company Overview
- 9.6.2. Company Snapshot
- 9.6.3. Financial Overview
- 9.6.4. Product Listing
- 9.6.5. Entropy
9.7. BTNX Inc
- 9.7.1. Company Overview
- 9.7.2. Company Snapshot
- 9.7.3. Financial Overview
- 9.7.4. Product Listing
- 9.7.5. Entropy
9.8. bioMerieux SA
- 9.8.1. Company Overview
- 9.8.2. Company Snapshot
- 9.8.3. Financial Overview
- 9.8.4. Product Listing
- 9.8.5. Entropy
9.9. Cardinal Health
- 9.9.1. Company Overview
- 9.9.2. Company Snapshot
- 9.9.3. Financial Overview
- 9.9.4. Product Listing
- 9.9.5. Entropy
9.10. Lab-Care Diagnostics (India) Pvt. Ltd
- 9.10.1. Company Overview
- 9.10.2. Company Snapshot
- 9.10.3. Financial Overview
- 9.10.4. Product Listing
- 9.10.5. Entropy
9.11. Creative Diagnostics
- 9.11.1. Company Overview
- 9.11.2. Company Snapshot
- 9.11.3. Financial Overview
- 9.11.4. Product Listing
- 9.11.5. Entropy
9.12. Meridian Bioscience Inc
- 9.12.1. Company Overview
- 9.12.2. Company Snapshot
- 9.12.3. Financial Overview
- 9.12.4. Product Listing
- 9.12.5. Entropy
9.13. F. Hoffmann-La Roche Ltd
- 9.13.1. Company Overview
- 9.13.2. Company Snapshot
- 9.13.3. Financial Overview
- 9.13.4. Product Listing
- 9.13.5. Entropy
9.14. Trinity Biotech
- 9.14.1. Company Overview
- 9.14.2. Company Snapshot
- 9.14.3. Financial Overview
- 9.14.4. Product Listing
- 9.14.5. Entropy
9.15. WERFEN
- 9.15.1. Company Overview
- 9.15.2. Company Snapshot
- 9.15.3. Financial Overview
- 9.15.4. Product Listing
- 9.15.5. Entropy
9.16. Elabscience Biotechnology Inc
- 9.16.1. Company Overview
- 9.16.2. Company Snapshot
- 9.16.3. Financial Overview
- 9.16.4. Product Listing
- 9.16.5. Entropy
9.17. Innova Medical Group Inc
- 9.17.1. Company Overview
- 9.17.2. Company Snapshot
- 9.17.3. Financial Overview
- 9.17.4. Product Listing
- 9.17.5. Entropy
9.18. CTK Biotech Inc
- 9.18.1. Company Overview
- 9.18.2. Company Snapshot
- 9.18.3. Financial Overview
- 9.18.4. Product Listing
- 9.18.5. Entropy
9.19. Atlas Medical GmbH
- 9.19.1. Company Overview
- 9.19.2. Company Snapshot
- 9.19.3. Financial Overview
- 9.19.4. Product Listing
- 9.19.5. Entropy
9.20. Wondfo
- 9.20.1. Company Overview
- 9.20.2. Company Snapshot
- 9.20.3. Financial Overview
- 9.20.4. Product Listing
- 9.20.5. Entropy